Proceeds from exercise of stock
purchase warrants 5 1,042
------------- -----------
Net cash provided by
financing activities 5 10,095
Effect of exchange rate changes
on cash (2) (28)
------------- -----------
Net change in cash (10,926) 5,050
Cash and cash equivalents at
beginning of period 11,867 9,022
------------- -----------
Cash and cash equivalents at end
of period $ 941 $ 14,072
============= ===========
Supplemental disclosure of cash
flow information:
Cash paid during period for
interest $ 9 $ 9
============= ===========
Supplemental Disclosure of
non-cash transactions:
Fair value of common stock,
stock options and stock
warrants issued as
consideration for asset
acquisition $ 9,605 $ -
============= ===========
(END) Dow Jones Newswires
November 10, 2022 18:00 ET (23:00 GMT)